There was also a trend towards a higher rate of discontinuation among patients with worse motor severity at baseline, but motor severity did not reach statistical significance as a predictor of prolonged use of OPC.
← all excerpts
Opicapone in Parkinson's disease: a real-world, multicenter, retrospective study to identify patient characteristics for sustained treatment benefit.
1
—
—